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INTRODUCTION
Hypertrophic cranial pachymeningitis (HCP) is a rare dis-
ease characterized by localized or diffuse thickening of the du-
ra mater of brain. A variety of conditions including intracra-
nial hypotension, infections, systemic autoimmune/vasculitic
disorders, malignancy, and meningioma can result in thick-
ened abnormally enhancing dura mater on gadolinium-en-
hanced magnetic resonance imaging (MRI) (1). Compression
of anatomic structures by thickened cranial dura mater may
cause clinical symptoms. Headache, cranial nerve palsies, and
ataxia are the most common clinical manifestations. HCP
may be infrequently associated with other fibrosclerotic dis-
eases including sclerosing cholangitis, Riedel thyroiditis epis-
cleritis, mediastinal fibrosis, and inflammatroy pseudotumor
(1). The diagnosis of undifferentiated connective tissue dis-
ease (UCTD) can be made in patients with clinical symptoms
and serological abnormalities suggestive of an autoimmune
disease, but not sufficient to fulfill the diagnostic criteria for
a defined CTD. Arthralgias, arthritis, Raynaud’s phenomenon,
mucocutaneus manifestations, sicca symptoms, and leucope-
nia are the most frequent manifestations of UCTD (2). 
Scleritis is characterized by a chronic inflammation that in-
volves the outermost coat and skeleton of the eye. Many pati-
ents with scleritis have systemic immune-mediated disease
such as rheumatoid arthritis, Wegener’s granulomatosis, rela-
psing polychondritis, systemic lupus erythematosus, inflam-
matory bowel disease, spondyloarthropathies, and polyarteri-
tis nodosa (3). We have found only one case report of pachy-
meningitis in a patient with UCTD (4). There has been only
a few case report of pachymeningitis with scleritis (5, 6).
To our knowledge, there is no previous report of pachym-
eningitis in a patient with UCTD presenting with scleritis.
Here, we describe a 37-yr-old male patient with UCTD who
suffered from scleritis and intracranial symptoms caused by
pachymeningitis.
CASE REPORT
A 37-yr-old man was referred to our emergency room wi-
th a provisional diagnosis of a subdural hemorrhage in April
18, 2009. He has complained of history of headache with int-
ermittent nausea and vomiting for two weeks. Brain comput-
ed tomography (CT) was done at local clinic to evaluate these
symptoms and unenhanced CT scans showed high-density
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A Case of Hypertrophic Cranial Pachymeningitis Presenting with 
Scleritis in a Patient with Undifferentiated Connective Tissue Disease
Hypertrophic cranial pachymeningitis (HCP) is an uncommon disorder that causes
a localized or diffuse thickening of the dura mater and has been reported to be infre-
quently associated with systemic autoimmune disorders such as Wegener’s gran-
ulomatosis, rheumatoid arthritis, sarcoidosis, Behçet’s disease, Sjögren syndrome,
and temporal arteritis. Here, we report a case of HCP initially presented with scleri-
tis and headache in a patient with undifferenciated connective tissue disease (UCTD).
HCP was initially suspected on brain magnetic resonance imaging and defined patho-
logically on meningial biopsy. Immunologic studies showed the presence of anti-RNP
antibody. After high dose corticosteroid therapy, the patient’s symptoms and radio-
logic abnormalities of brain were improved. Our case suggested that HCP should
be considered in the differential diagnosis of headache in a patient with UCTD pre-
senting with scleritis.
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areas along the left tentorium cerebelli. He had been man-
aged with prednisolone (5-30 mg/day) by ophthalmologist
in our hospital under the diagnosis of scleritis since January
2008. Thirty milligrams of prednisone was administrated for
7 days initially and then tapered. At the time of symptom
developing, the patient was being treated with prednisone
10 mg. The patient has complained of intermittent hand joint
pain, swelling, and Raynaud’s phenomenon for 3 yr. He had
neither other past history nor familial history. He denied a
history of head trauma. The initial vital signs were stable.
On physical examination, both eyes appeared red. No arthrit-
ic pain was observed. The rest of the clinical examination was
normal including neurological examination. Complete blood
cell counts were within normal limits. Blood analysis showed
an erythrocyte sedimentation rate of 48 mm/hr and C-reac-
tive protein of 44.49 mg/L (normal <3.0 mg/L). The values
for blood glucose, liver function, renal function, electrolytes,
C3, and C4 were their normal ranges. In the tests for autoan-
tibody, the titer of antinuclear antibody was 1:1,600 and anti-
ribonucleoprotein (RNP) antibody 63.42 EU. But, antibod-
ies to double stranded DNA, Sm, Ro, La, Scl-7, Jo-1, centro-
mere, nucleosomes, and histone were negative. Rheumatoid
factor, anti-CCP antibody, and ANCA were also negative.
Tests for syphilis, hepatitis B surface antigen, anti-HBs anti-
body, anti-HCV antibody, anti-HTLV-1 antibody, and anti-
HIV were negative. The level of serum angiotensin-convert-
ing enzyme was normal. The urinalysis was normal. CSF exam-
ination showed increased opening pressure (250 mmH2O),
proteins (99 mg/dL), and cells (28/μ L, lymphocyte 98%).
CSF cultures and staining for acid-fast bacilli, bacteria and
fungi were negative. The patient complained of diplopia on
the 2nd hospital day and peripheral type facial palsy on the
10th hospital day. A chest radiography showed calcified nod-
ules in the right upper lobe. Chest CT showed 3.3×1.6 cm
sized irregular soft tissue density in the left upper anterior
pericardial region (Fig. 1A). Brain MRI showed a left tento-
rium cerebelli lesion that was iso-intensity on T1 weighted
MRI and hypointensity on T2-weighted imaging with mark-
ed enhancement after gadolinium (Fig. 2A). On the 19th hos-
pital day, the patient underwent biopsy of left tentorium cere-
bella. Meningeal biopsy showed fibrosis accompanied by the
infiltration of chronic inflammatory cells without evidence
of vasculitis or granuloma (Fig. 3). From the 3rd hospital day
after meningeal biopsy, 20 mg of intravenous dexamethasone
was administered for 6 days, then changed to oral predniso-
lone (1 mg/kg) with gradual tapering. Follow-up MRI, per-
formed at 4 weeks after the initial glucocorticoid therapy,
showed much regression of dural enhancement (Fig. 2B). A
follow-up chest CT scan 5 months after the initial glucocor-
ticoid therapy demonstrated a marked decrease of the size of
the pericardial mass (Fig. 1B). He recovered from diplopia
and facial nerve palsy with glucocorticoid therapy. Current-
ly, after 10 months of follow-up after introduction of glucocor-
ticoid, the patient is doing well with low doses of glucocor-
ticoid.
DISCUSSION 
Hypertrophic pachymeningitis is defined as localized or dif-
fuse thickening of the dura mater. Radiculopathy, myelopathy
or a combination of the two has also been observed in patients
with hypertrophic spinal pachymeningitis (7). Chief symp-
toms of hypertrophic cranial pachymeningitis are headache
with or without intracranial neurologic manifestations such
as cranial neuropathy and cerebellar dysfunction (8). As in this
case, a patient with cranial pachymenigitis presenting with
headache may be initially misdiagnosed as acute subdural
hemorrhage (9, 10). Fibrous encasement and ischemic damage
to cranial nerves may lead to cranial nerve palsies (11). Two
patterns of cranial nerve involvement have been described,
based on the site of dural inflammation, cavernous sinus to
Fig. 1. Enhanced computed tomography of the chest. (A) In April 2008, irregular soft tissue density measuring about 3.3×1.6 cm was
seen in the left upper anterior pericardial region (arrow). (B) In October 2008, 5 months after the initial glucocorticoid therapy, follow up
image demonstrated more regression state of the left upper anterior soft tissue density, measuring about 1.7×0.7 cm (arrow).
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superior orbital fissure involvement (anterior involvement)
and falcotentorial to posterior fossa dural involvement (pos-
terior involvement). In the case of posterior involvement, cra-
nial nerves 5 to 12 may be involved, with involvements of
the 8th nerve being the most common (8). In our case, the
patient suffered from facial nerve palsy.
MRI is very useful to evaluate dura mater disease. In case
of pachymeningitis, MRI showed characteristic findings such
as hypo-isodense dura on T1 and T2WI and marked enhance-
ment after contrast administration, but these findings are not
pathognomonic of cranial pachymeningitis. Many conditions
including intracranial hypotension, infections, metastatic or
infiltrative malignancy, sarcoidosis, vasculitis, and connective
tissue diseases can cause thickening of the dura mater. In our
case, we could exclude the possibility of intracranial hypoten-
sion, infections and malignant tumors as cause of dural thick-
ening on the base of the results of CSF study and histopatho-
logic examination. Connective tissue diseases such as Wegen-
er’s granulomatosis, rheumatoid arthritis, sarcoidosis, Behçet’s
disease, and Sjögren syndrome have been reported to be asso-
ciated with hypertrophic cranial pachymeningitis (1). In this
case, arthritis and Raynaud’s phenomenon for more than three
years and the presence of with scleritis (3). There has been only
a few case report of HCP with scleritis. S anti-nuclear anti-
Fig. 2. Magnetic resonance image of the brain. (A) On the 3rd hospital day, axial T1-weighted contrast-enhanced magnetic resonance
image shows diffuse thick dural enhancement along the left tentorium and left cerebellar surface. (B). In 4 weeks after the initial glucocor-
ticoid treatment, follow-up magnetic resonance image demonstrated nearly complete regression of dural enhancement. Only very thin
dural enhancement remained.
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Fig. 3. Photomicrographs of sections of dura mater tissue stained with hematotoxylin and eosin,×400. (A) Thickened dura mater revealed
extensive fibrosis. (B) Acute and chronic inflammatory infiltrate is consisting chiefly of plasma cells with additional lymphocytes.
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body and anti-RNP antibodies suggested a systemic autoim-
mune disease, but the patient did not meet the existing clas-
sification criteria for a connective tissue disease. Therefore,
the patient was diagnosed as having undifferentiated connec-
tive tissue. There has been one case report of hypertrophic cra-
nial pachymeningitis in a patient with UCTD (1). 
Scleritis which is characterized by a chronic inflammation
that involves the outermost coat and skeleton of the eye is
often associated with immune-mediated systemic inflam-
matory condition (3). Rheumatoid arthritis and Wegener’s
granulomatosis are known to be the most common systemic
immune mediated diseases associated with scleritis (3). UCTD
is reported to be rarely associated with scleritis (3). Ueda et
al. (5) reported a case of scleritis with pachymeningitis which
was diagnosed on the basis of brain MRI findings. Starosta
et al. (6) reported a case of pachymenigitis with scleritis in a
patient with RA. As far as we know, this is the first report
of HCP in a patient with UCTD presenting with scleritis.
HCP may be infrequently associated with other fibroscle-
rotic diseases such as sclerosing cholangitis, episcleritis, Riedel
thyroiditis, testicular fibrosis, mediastinal fibrosis, and infl-
ammatoy pseudotumor (1). Inflammatory pseudotumor is a
quasineoplastic lesion consisting of inflammatory cells and
myofibroblastic spindle cells. Inflammatory pseudotumor is
thought to be associated with either infection or autoimmune
mechanism (12).
The differential diagnosis of pericardial masses includes
pericardial cyst, hematoma, metastatic neoplasm, and prima-
ry neoplasm (13). Metastatic neoplasm such as mesothelioma,
lymphoma, sarcoma, liposarcoma may be suggested by CT
findings of effusion and irregularly thickened pericardium or
pericardial mass. Primary benign pericardial tumors include
hemangioma, lipoma, teratoma, and fibroma. Low attenua-
tion and depiction of calcium or fat in a pericardial mass on
CT images suggest lipoma and teratoma, respectively. Malig-
nant primary tumors include lymphoma, mesothelioma, sar-
coma, and liposarcoma and pericardial effusion are frequent-
ly associated. Biopsy was not done because there was a high
operative risk and was not pericardial effusion which was usu-
ally accompanied with a lymphoma. Although MRI and
biopsy were not performed for pericardial mass, the remark-
able corticosteroid response, physiologic amount of pericar-
dial effusion, and CT findings favor a diagnosis of inflamma-
tory pseudotumor in our case. 
There is no consensus on the adequate therapeutic manage-
ment of HCP. Although spontaneous resolution has been
reported (14), glucocorticoid therapy has been considered as
the mainstay of treatment in patients with HCP. If clinical
manifestations are resistant or dependent to glucocorticoid
therapy, additional methotrexate or azathioprine may be help-
ful (15, 16).
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